OLFM4 and chronic myelogenous leukemia, BCR-ABL1 positive: Consistent with RNAseq data, qPCR analysis revealed the augmentation of OLFM4 expression by imatinib in CML iCD34+ cells, including all four OLFM4a–OLFM4d mRNA isoforms (Fig. 4d).